Treating atherosclerosis
US8507646B2 · kind B2 · utility
0Cited by
4References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 23, 2007 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Mar 9, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application features methods and compositions for treating patients suffering from atherosclerosis or at risk for developing atherosclerosis. The treatment includes administering to the patient a pharmaceutical composition that includes an agent capable of blocking the interaction between uPA and its receptor uPAR, e.g., an ATF or a fragment thereof, an anti-uPA antibody, a uPAR or a fragment thereof, or an antibody that specifically binds to uPAR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.